Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Lessons from the STEP-TB Project.
Accessed November 2017.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Overcoming Barriers to TB Control
Training Curriculum
August 2011
Scientific advice
Prevention and control of communicable diseases in prison settings.
Joining efforts to control two trelated global epidemics.
Stop TB Communicable Diseases
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
A Guide For Multicentre Trials in High-Burden Countries
ERJ Open Res 2017; 3: 00002-2017